Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Breast Cancer

  Free Subscription

Articles published in Eur J Surg Oncol

Retrieve available abstracts of 105 articles:
HTML format

Single Articles

    July 2024
  1. GEDFEW M, Getie A, Akalu TY, Ayenew T, et al
    Recurrence and associated factors of breast cancer among women in sub saharan africa, systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108528.
    PubMed     Abstract available

  2. GILL SS, Shukla A, Namireddy SR, Moin S, et al
    Exercise and recovery after surgery in patients with breast cancer: An analysis of the literature.
    Eur J Surg Oncol. 2024;50:108525.
    PubMed     Abstract available

  3. SCHIAVONE A, Ventimiglia F, Zarba Meli E, Taffurelli M, et al
    Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus.
    Eur J Surg Oncol. 2024;50:108351.
    PubMed     Abstract available

    June 2024
  4. SCHIPPER RJ, de Bruijn A, van der Sangen MJC, Bloemen JG, et al
    Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study.
    Eur J Surg Oncol. 2024;50:108472.
    PubMed     Abstract available

  5. PLOUMEN RAW, Claassens EL, Kooreman LFS, Keymeulen KBMI, et al
    Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2024;50:108465.
    PubMed     Abstract available

  6. SPOOR J, Heeling E, Collewijn RC, van der Ploeg IMC, et al
    Intraoperative frozen section of subareolar tissue in nipple-sparing mastectomy: Towards a less is more approach.
    Eur J Surg Oncol. 2024;50:108320.
    PubMed     Abstract available

    May 2024
  7. YEO HAO XUAN M, Masuda Y
    Reply to: Surgery vs. non-surgery for liver metastases from primary breast cancer.
    Eur J Surg Oncol. 2024 May 29:108446. doi: 10.1016/j.ejso.2024.108446.

  8. HAN W, Shi CT, Wang HN
    Surgery vs. non-surgery for liver metastases from primary breast cancer.
    Eur J Surg Oncol. 2024 May 28:108445. doi: 10.1016/j.ejso.2024.108445.

  9. SAQIB HWU, Arshad HUA
    "Navigating breast cancer treatment: The role of early genetic testing".
    Eur J Surg Oncol. 2024;50:108392.

    April 2024
  10. SASADA S, Nagura N, Shimo A, Ogiya A, et al
    Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study.
    Eur J Surg Oncol. 2024;50:108360.
    PubMed     Abstract available

  11. OGIYA A, Kimura K, Ueno T, Iwase T, et al
    Time trend of breast cancer-related lymphedema according to body mass index.
    Eur J Surg Oncol. 2024;50:108350.
    PubMed     Abstract available

  12. APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
    Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
    Eur J Surg Oncol. 2024;50:108324.
    PubMed     Abstract available

  13. NAVARRO AS, Omalek D, Chaltiel L, Vaysse C, et al
    Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancer.
    Eur J Surg Oncol. 2024;50:107998.
    PubMed     Abstract available

  14. MEATTINI I, Kunkler IH
    Omission of radiation therapy after breast conserving surgery for older women at low-risk of local recurrence: One option among many.
    Eur J Surg Oncol. 2024;50:108058.
    PubMed     Abstract available

  15. SAE-LIM C, Lai HW, Lin SL, Huang HI, et al
    Is minimal-accessed (endoscopic- or robotic-assisted) nipple-sparing mastectomy contraindicated for large breasts?
    Eur J Surg Oncol. 2024;50:108030.
    PubMed     Abstract available

    March 2024
  16. TASOULIS MK, Muktar S, Smith I, Roche N, et al
    Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2024;50:108277.
    PubMed     Abstract available

  17. DI LENA E, Wong SM, Iny E, Mashal S, et al
    Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study.
    Eur J Surg Oncol. 2024;50:108266.
    PubMed     Abstract available

  18. LOVELAND-JONES C, Gaughan J, Caudle A, Murphy B, et al
    Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry.
    Eur J Surg Oncol. 2024;50:108245.
    PubMed     Abstract available

    February 2024
  19. SKJERVEN HK, Myklebust EM, Korvald C, Stubberud K, et al
    Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.
    Eur J Surg Oncol. 2024;50:107938.
    PubMed     Abstract available

  20. VAN DAM MA, Bijlstra OD, Faber RA, Warmerdam MI, et al
    Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery.
    Eur J Surg Oncol. 2024;50:107317.
    PubMed     Abstract available

    January 2024
  21. CAVALCANTE FP, Zerwes FP, Souza ABA, Ziegelmann PK, et al
    The use of blue dye alone for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initially node-positive breast cancer.
    Eur J Surg Oncol. 2024;50:107967.
    PubMed     Abstract available

  22. ROCCO N, Ghilli M, Curcio A, Bortul M, et al
    Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC).
    Eur J Surg Oncol. 2024;50:107954.
    PubMed     Abstract available

  23. RUBIO IT, Wyld L, Marotti L, Athanasiou A, et al
    European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
    Eur J Surg Oncol. 2024;50:107292.
    PubMed     Abstract available

    December 2023
  24. OKUYAMA A, Takei J, Ogawa A
    Perioperative treatments for and postoperative activity of daily living of patients with early-stage breast cancer according to age group: A retrospective observational study.
    Eur J Surg Oncol. 2023;50:107323.
    PubMed     Abstract available

  25. REN C, Sun J, Kong L, Wang H, et al
    Breast surgery for patients with de novo metastatic breast cancer: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2023;50:107308.
    PubMed     Abstract available

    November 2023
  26. MASUDA Y, Yeo MHX, Syn NL, Goh BKP, et al
    Surgery for liver metastases from primary breast cancer: A reconstructed individual patient data meta-analysis.
    Eur J Surg Oncol. 2023;50:107277.
    PubMed     Abstract available

  27. QUDDUS R, Banks J, Morgan JL, Martin C, et al
    Outcomes of complex oncoplastic breast surgery in older women. Analysis of data from the Age Gap cohort study.
    Eur J Surg Oncol. 2023;49:107075.
    PubMed     Abstract available

  28. MOHRMANN S, Kolberg L, Jager B, Hoffmann J, et al
    Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.
    Eur J Surg Oncol. 2023;49:107031.
    PubMed     Abstract available

  29. VIRZI D, Caruso F, Castiglione G, Marino M, et al
    Thoraco-dorsal artery perforator flap for totally autologous primary breast reconstruction. Assessment of feasibility with standard reporting scales.
    Eur J Surg Oncol. 2023;49:106988.
    PubMed     Abstract available

    October 2023
  30. MURRAY A, Francks L, Hassanein ZM, Lee R, et al
    Breast cancer surgical decision-making. Experiences of Non-Caucasian women globally. A qualitative systematic review.
    Eur J Surg Oncol. 2023;49:107109.
    PubMed     Abstract available

  31. LAI SW, Hwang BF, Liu CS, Liao KF, et al
    Comment on "Prophylactic aspirin intake and breast cancer risk: A systematic review and meta-analysis of observational cohort studies".
    Eur J Surg Oncol. 2023;49:107104.

  32. MAGGI N, Rais D, Nussbaumer R, Levy J, et al
    The American Society of Breast Surgeons classification system for oncoplastic breast conserving surgery independently predicts the risk of delayed wound healing.
    Eur J Surg Oncol. 2023;49:107032.
    PubMed     Abstract available

  33. SISO C, Esgueva A, Rivero J, Morales C, et al
    Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment.
    Eur J Surg Oncol. 2023;49:106938.
    PubMed     Abstract available

    September 2023
  34. VROLIJK JJ, Young-Afat DA, Mureau MAM, Rakhorst HA, et al
    Ensuring access to post-cancer breast reconstructions: COVID-19 lessons from the Dutch Breast Implant Registry.
    Eur J Surg Oncol. 2023;49:106984.
    PubMed     Abstract available

  35. DE ROOIJ L, Kimman ML, Spiekerman van Weezelenburg MA, van Kuijk SMJ, et al
    Economic evaluation of flap fixation techniques after mastectomy: Results of a double-blind randomized controlled trial (SAM-trial).
    Eur J Surg Oncol. 2023;49:107003.
    PubMed     Abstract available

    August 2023
  36. ESGUEVA AJ, Sobrido C, Diaz-Botero S, Diez-Uriel E, et al
    Intraoperative ultrasound margin evaluation as a tool to reduce positive superficial margins in nipple and skin sparing mastectomy in breast cancer patients.
    Eur J Surg Oncol. 2023;49:107049.
    PubMed     Abstract available

  37. QIU PF, Lv Q, Zhao WH, Huang YX, et al
    Development and validation of a nomogram for predicting internal mammary sentinel node metastasis in breast cancer patients.
    Eur J Surg Oncol. 2023;49:107040.
    PubMed     Abstract available

  38. ERTANSEL BN, Rajagopal S, Lodhia S, Boutsikos G, et al
    Mini review: Breast cancer care in individuals with differences of sexual development.
    Eur J Surg Oncol. 2023;49:107004.
    PubMed     Abstract available

  39. MARTINEZ-PEREZ JL, Pascual-Dapena A, Pardo Y, Ferrer M, et al
    Validation of the Spanish electronic version of the BREAST-Q questionnaire.
    Eur J Surg Oncol. 2023;49:1417-1422.
    PubMed     Abstract available

    July 2023
  40. GULIS K, Ellbrant J, Svensjo T, Skarping I, et al
    A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2023;49:1189-1195.
    PubMed     Abstract available

  41. LEE KT, Kim J, Jeon BJ, Pyon JK, et al
    Association of the breast reconstruction modality with the development of postmastectomy lymphedema: A long-term follow-up study.
    Eur J Surg Oncol. 2023;49:1177-1183.
    PubMed     Abstract available

    June 2023
  42. ZHONG G, Song D, Lou W, Wei B, et al
    Pathological complete response rate and clinical outcome after neoadjuvant therapy of HER2-low breast cancer: A National Cancer Database Analysis.
    Eur J Surg Oncol. 2023 Jun 22:S0748-7983(23)00563.
    PubMed     Abstract available

  43. MENG X, Chang X, Qin P, Li Y, et al
    Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer.
    Eur J Surg Oncol. 2023 Jun 12:S0748-7983(23)00546.
    PubMed     Abstract available

  44. BAKIERZYNSKA M, Cullinane MC, Redmond HP, Corrigan M, et al
    Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies.
    Eur J Surg Oncol. 2023 Jun 7:S0748-7983(23)00509.
    PubMed     Abstract available

    May 2023
  45. NOGUCHI M, Inokuchi M, Yokoi-Noguchi M, Morioka E, et al
    The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer.
    Eur J Surg Oncol. 2023 May 19:S0748-7983(23)00506.
    PubMed     Abstract available

    April 2023
  46. GUTH U, Elfgen C, Zadeh SN, Meier S, et al
    The impact of intraoperative frozen section in patients with clinically node-negative breast cancer (cN0/ycN0) who received neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2023 Apr 25:S0748-7983(23)00477.
    PubMed     Abstract available

  47. KASTORA SL, Karakatsanis A, Masannat YA
    Comprehending the impact of #Breastcancer, #Breastsurgery and related hashtags on Twitter: A content and social network cross-sectional analysis #Breastcancer#Breastsurgery.
    Eur J Surg Oncol. 2023;49:716-723.
    PubMed     Abstract available

    March 2023
  48. FALEH S, Prakash I, Eisenberg E, Basik M, et al
    Predictors of nodal metastases in early stage HER2+ breast cancer: Deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgery.
    Eur J Surg Oncol. 2023 Mar 31:S0748-7983(23)00423.
    PubMed     Abstract available

  49. DEL CASTILLO A, Gomez-Modet S, Mata JM, Tejedor L, et al
    Targeted axillary dissection using Radioguided Occult Lesion Localization technique in the clinically negative marked lymph node after neoadjuvant treatment in breast cancer patients.
    Eur J Surg Oncol. 2023 Mar 10:S0748-7983(23)00379.
    PubMed     Abstract available

  50. VANHAEVERBEEK M, Catteau X, Noel JC, Simon P, et al
    Comments on: "The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review and meta-analysis" by C.Cullinane and al.
    Eur J Surg Oncol. 2023;49:673-674.

  51. SKJERVEN HK, Myklebust EM, Korvald C, Porojnicu AC, et al
    Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women.
    Eur J Surg Oncol. 2023;49:575-582.
    PubMed     Abstract available

  52. VARTHOLOMATOS G, Alexiou GAlpha, Tatsi V, Harissis H, et al
    Next-generation margin evaluation techniques in breast conserving surgery: A memorandum on intraoperative flow cytometry.
    Eur J Surg Oncol. 2023;49:675-676.

    February 2023
  53. BARRY PA, Harborough K, Sinnett V, Heeney A, et al
    Clinical utility of axillary nodal markers in breast cancer.
    Eur J Surg Oncol. 2023 Feb 1:S0748-7983(22)01365.
    PubMed     Abstract available

    January 2023
  54. TAMMINEN A, Huttunen T, Meretoja T, Niinikoski L, et al
    Ultrasonic scissors decrease postoperative bleeding complications in mastectomy: A retrospective multicenter cohort study on 728 patients.
    Eur J Surg Oncol. 2023;49:68-75.
    PubMed     Abstract available

  55. ARISTOKLEOUS I, Oberg J, Pantiora E, Sjokvist O, et al
    Effect of standardised surgical assessment and shared decision-making on morbidity and patient satisfaction after breast conserving therapy: A cross-sectional study.
    Eur J Surg Oncol. 2023;49:60-67.
    PubMed     Abstract available

    November 2022
  56. LEONARD-MURALI S, Nathanson SD, Springer K, Baker P, et al
    Early breast cancer survival of black and white American women with equal diagnostic and therapeutic management.
    Eur J Surg Oncol. 2022 Nov 28:S0748-7983(22)00829.
    PubMed     Abstract available

  57. PARK Y, Shin YS, Kim K, Shin KH, et al
    Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06).
    Eur J Surg Oncol. 2022 Nov 24:S0748-7983(22)00827.
    PubMed     Abstract available

  58. KWON CH, Seo HI, Kim DU, Han SY, et al
    HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
    Eur J Surg Oncol. 2022 Nov 2. pii: S0748-7983(22)00712.
    PubMed     Abstract available

    September 2022
  59. KAIDAR-PERSON O, Weber WP, Kuhn T, Poortmans P, et al
    The forgotten node: Axillary surgery mandates expertise.
    Eur J Surg Oncol. 2022;48:1922-1924.
    PubMed     Abstract available

    August 2022
  60. MORGAN JL, Bromley HL, Dave RV, Masannat Y, et al
    Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study.
    Eur J Surg Oncol. 2022 Aug 30. pii: S0748-7983(22)00556.
    PubMed     Abstract available

  61. GENTILE D, Losurdo A, Sagona A, Zuradelli M, et al
    Surgical management of BRCA-mutation carriers: A single institution experience.
    Eur J Surg Oncol. 2022;48:1706-1712.
    PubMed     Abstract available

    July 2022
  62. ZONGO N, Ouedraogo S, Bado C, Kabore A, et al
    Survival of patients operated on for breast cancer in Ouagadougou/Burkina Faso.
    Eur J Surg Oncol. 2022 Jul 16. pii: S0748-7983(22)00543.
    PubMed     Abstract available

  63. NEAL D, Morgan JL, Kenny R, Ormerod T, et al
    Is there evidence of age bias in breast cancer health care professionals' treatment of older patients?
    Eur J Surg Oncol. 2022 Jul 16. pii: S0748-7983(22)00545.
    PubMed     Abstract available

  64. CHA C, Jeong J, Kim HK, Nam SJ, et al
    Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis.
    Eur J Surg Oncol. 2022 Jul 16. pii: S0748-7983(22)00547.
    PubMed     Abstract available

  65. CONVERSANO A, Abbaci M, Karimi M, Mathieu MC, et al
    Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study).
    Eur J Surg Oncol. 2022 Jul 8. pii: S0748-7983(22)00546.
    PubMed     Abstract available

  66. CULLINANE C, Byrne J, Kelly L, O Sullivan M, et al
    The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis.
    Eur J Surg Oncol. 2022;48:1464-1474.
    PubMed     Abstract available

    June 2022
  67. RUTHERFORD CL, Goodman D, Lannigan A
    A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.
    Eur J Surg Oncol. 2022 Jun 10. pii: S0748-7983(22)00488.
    PubMed     Abstract available

  68. HOFFMAN A, Ashkenazi I
    Reply to: Next-generation margin evaluation techniques in breast conserving surgery: A memorandum on intraoperative flow cytometry.
    Eur J Surg Oncol. 2022;48:1439.

    May 2022
  69. ZWAKMAN M, Francken AB
    Reply to letter to the editor: Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancer.
    Eur J Surg Oncol. 2022 May 26. pii: S0748-7983(22)00433.

  70. WINTERS H, Tielemans HJP, Hummelink S, Slater NJ, et al
    DIEP flap breast reconstruction combined with vascularized lymph node transfer for patients with breast cancer-related lymphedema.
    Eur J Surg Oncol. 2022 May 20. pii: S0748-7983(22)00432.
    PubMed     Abstract available

  71. KAILIDES M, Constantinides J
    Letter to the editor: "Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancer".
    Eur J Surg Oncol. 2022 May 18. pii: S0748-7983(22)00434.

    April 2022
  72. OZMEN T, Layton C, Friedman-Eldar O, Melnikau S, et al
    Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (SLYMPHA) for the prevention of breast cancer-related lymphedema after axillary lymph node dissection using bioimpedance spectroscopy.
    Eur J Surg Oncol. 2022 Apr 30. pii: S0748-7983(22)00424.
    PubMed     Abstract available

  73. MAIRE M, Debled M, Petit A, Fournier M, et al
    Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
    Eur J Surg Oncol. 2022 Apr 29. pii: S0748-7983(22)00415.
    PubMed     Abstract available

  74. KUBO A, Tanei T, R Pradipta A, Morimoto K, et al
    Comparison of "click-to-sense" assay with frozen section analysis using simulated surgical margins in breast cancer patients.
    Eur J Surg Oncol. 2022 Apr 13. pii: S0748-7983(22)00380.
    PubMed     Abstract available

  75. MORGAN JL, Cheng V, Barry PA, Copson E, et al
    The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making.
    Eur J Surg Oncol. 2022 Apr 4. pii: S0748-7983(22)00158.
    PubMed     Abstract available

  76. CATANUTO G, Rocco N, Maglia A, Barry P, et al
    Text mining and word embedding for classification of decision making variables in breast cancer surgery.
    Eur J Surg Oncol. 2022 Apr 1. pii: S0748-7983(22)00124.
    PubMed     Abstract available

  77. O'CONNELL RL, Sharma B, Van Kerckhoven L, Mehdi AS, et al
    Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
    Eur J Surg Oncol. 2022;48:748-751.
    PubMed     Abstract available

  78. TUKIAMA R, Vieira RAC, Moura ECR, Oliveira AGC, et al
    Oncologic safety of breast reconstruction with autologous fat grafting: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022;48:727-735.
    PubMed     Abstract available

  79. FARANTE G, Toesca A, Magnoni F, Lissidini G, et al
    Advances and controversies in management of breast ductal carcinoma in situ (DCIS).
    Eur J Surg Oncol. 2022;48:736-741.
    PubMed     Abstract available

    February 2022
  80. HOFFMAN A, Ashkenazi I
    The efficiency of MarginProbe in detecting positive resection margins in epithelial breast cancer following breast conserving surgery.
    Eur J Surg Oncol. 2022 Feb 19. pii: S0748-7983(22)00115.
    PubMed     Abstract available

  81. WANG Y, Song Z, Zhang S, Wang X, et al
    Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022 Feb 18. pii: S0748-7983(22)00113.
    PubMed     Abstract available

  82. ZWAKMAN M, Tan A, Boersma C, Klinkenbijl JHG, et al
    Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancer.
    Eur J Surg Oncol. 2022 Feb 12. pii: S0748-7983(22)00088.
    PubMed     Abstract available

  83. HOURSTON G, Joglekar S, Down S, Downey S, et al
    Has the time come for de-escalation in oncoplastic breast conserving surgery?
    Eur J Surg Oncol. 2022;48:309-311.

    January 2022
  84. BJORNSTROM M, Niinikoski L, Meretoja TJ, Leidenius MHK, et al
    Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas.
    Eur J Surg Oncol. 2022;48:67-72.
    PubMed     Abstract available

    November 2021
  85. CSERNI G, Ambrozay E, Serenyi P, Bori R, et al
    Preoperative axillary nodal staging of invasive lobular breast cancer with ultrasound guided fine needle aspiration in patients with suspicious ultrasound findings versus aspiration in all patients - A retrospective single institutional analysis.
    Eur J Surg Oncol. 2021 Nov 30. pii: S0748-7983(21)00939.
    PubMed     Abstract available

  86. JOUKAINEN S, Okuma H, Kaarela O, Laaksonen E, et al
    Can supine breast magnetic resonance imaging help hit the target in extreme oncoplastic surgery?
    Eur J Surg Oncol. 2021;47:2788-2796.
    PubMed     Abstract available

  87. O'DONNELL JPM, Murphy D, Ryan EJ, Gasior SA, et al
    Optimal reconstructive strategies in the setting of post-mastectomy radiotherapy - A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2021;47:2797-2806.
    PubMed     Abstract available

  88. WHISKER L, Barber M, Egbeare D, Gandhi A, et al
    Biological and synthetic mesh assisted breast reconstruction procedures: Joint guidelines from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons.
    Eur J Surg Oncol. 2021;47:2807-2813.
    PubMed     Abstract available

    October 2021
  89. PLOUMEN RAW, Keymeulen KBMI, Kooreman LFS, van Kuijk SMJ, et al
    The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study.
    Eur J Surg Oncol. 2021 Oct 22. pii: S0748-7983(21)00765.
    PubMed     Abstract available

  90. ATHANASIOU C, Mallidis E, Tuffaha H
    Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2021 Oct 11. pii: S0748-7983(21)00751.
    PubMed     Abstract available

  91. DIXON JM, Kunkler IH, Russell N, Thomssen C, et al
    Postmastectomy radiotherapy for all node positive patients: The case against.
    Eur J Surg Oncol. 2021;47:2515-2520.
    PubMed     Abstract available

  92. MATTAR D, Di Filippo A, Invento A, Radice D, et al
    Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology.
    Eur J Surg Oncol. 2021;47:2499-2505.
    PubMed     Abstract available

  93. WANG J, Tang H, Yin K, Li X, et al
    Second invasive breast cancers in patients treated with breast-conserving therapy.
    Eur J Surg Oncol. 2021;47:2492-2498.
    PubMed     Abstract available

  94. NASUTE FAUERBACH PV, Tyryshkin K, Rodrigo SP, Rudan J, et al
    Lack of definitive presurgical pathological diagnosis is associated with inadequate surgical margins in breast-conserving surgery.
    Eur J Surg Oncol. 2021;47:2483-2491.
    PubMed     Abstract available

    September 2021
    Oncoplastic breast surgery: Look good feel better.
    Eur J Surg Oncol. 2021;47:2211.

  96. GILMOUR A, Cutress R, Gandhi A, Harcourt D, et al
    Oncoplastic breast surgery: A guide to good practice.
    Eur J Surg Oncol. 2021;47:2272-2285.
    PubMed     Abstract available

    August 2021
  97. PUJJI OJS, Blackhall V, Romics L, Vidya R, et al
    Systematic review of partial breast reconstruction with pedicled perforator artery flaps: Clinical, oncological and cosmetic outcomes.
    Eur J Surg Oncol. 2021;47:1883-1890.
    PubMed     Abstract available

  98. LOZAR T, Zgajnar J, Perhavec A, Blatnik A, et al
    Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
    Eur J Surg Oncol. 2021;47:1900-1906.
    PubMed     Abstract available

    July 2021
  99. BARGALLO-ROCHA JE, Torres-Dominguez JA, Reynoso-Noveron N, Rivera-Corona J, et al
    Trends in breast-conserving surgery in Mexico after the implementation of a public health insurance system.
    Eur J Surg Oncol. 2021;47:1601-1605.
    PubMed     Abstract available

  100. EDIRISOORIYA M, Jack W, Twelves D, Royds J, et al
    Diagnostic accuracy of core biopsy in patients presenting with axillary lymphadenopathy and suspected non-breast malignancy.
    Eur J Surg Oncol. 2021;47:1575-1580.
    PubMed     Abstract available

    June 2021
  101. WU ZY, Han HH, Kim HJ, Lee J, et al
    Locoregional recurrence following nipple-sparing mastectomy with immediate breast reconstruction: Patterns and prognostic significance.
    Eur J Surg Oncol. 2021;47:1309-1315.
    PubMed     Abstract available

    May 2021
  102. FRANCESCHINI G, Masetti R
    Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future?
    Eur J Surg Oncol. 2021;47:1225-1226.

    April 2021
  103. SCHOP SJ, Joosen MEM, Wolswijk T, Heuts EM, et al
    Quality of life after autologous fat transfer additional to prosthetic breast reconstruction in women after breast surgery: A systematic review.
    Eur J Surg Oncol. 2021;47:772-777.
    PubMed     Abstract available

  104. DE ROOIJ L, Bosmans JWAM, van Kuijk SMJ, Vissers YLJ, et al
    A systematic review of seroma formation following drain-free mastectomy.
    Eur J Surg Oncol. 2021;47:757-763.
    PubMed     Abstract available

  105. MIYOSHI T, Yamaguchi S, Fujimoto H, Yoshioka S, et al
    A new method to optimize resection area using a radiation treatment planning system and deformable image registration for breast-conserving surgery after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021;47:789-795.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.